Science News, Information and Educational Resources


Science Feed Image

    		•    
    This is a video response due to the fact of people nip picking at subjects.what i mean by this i tell bob to read book A and he just reads 1 paragraph of the.
    George Orwell, 1984, and finding - http://doubleplusbad.com/  ...Read On

     Cancer is the world’s top “economic killer” as well as its likely leading cause of death, the American Cancer Society contends in a new report it will present at a global cancer conference in China this week.

    Cancer costs more in productivity and lost life than AIDS, malaria, the flu and other diseases that spread person-to-person, the report concludes.

    Chronic diseases including cancer, heart disease and diabetes account for more than 60 percent of deaths worldwide but less than 3 percent of public and private funding for global health, said Rachel Nugent of the Center for Global Development, a Washington-based policy research group.

    Money shouldn’t be taken away from fighting diseases that spread person-to-person, but the amount devoted to cancer is way out of whack with the impact it has, said Dr. Otis Brawley, the cancer society’s chief medical officer.

    Cancer’s economic toll was $895 billion in 2008 – equivalent to 1.5 percent of the world’s gross domestic product, the report says. That’s in terms of disability and years of life lost – not the cost of treating the disease, which wasn’t addressed in the report.

    The World Health Organization has long predicted that cancer would overtake heart disease this year as the leading cause of death. About 7.6 million people died of cancer in 2008, and about 12.4 million new cases are diagnosed each year.

    Tobacco use and obesity are fueling a rise in chronic diseases, while vaccines and better treatments have led to drops in some infectious diseases.

    Many groups have been pushing for more attention to non-infectious causes of death, and the United Nations General Assembly has set a meeting on this a year from now. Some policy experts are comparing it to the global initiative that led to big increases in spending on AIDS nearly a decade ago.

    “This needs to be discussed at the UN – how we are going to deal with this” rising burden of chronic disease, said Dr. Andreas Ullrich, medical officer for cancer control at WHO.

    The answer is “not a fight against each other,” but more cooperation on areas that overlap, such as cancers with infectious causes, such as cervical cancer and HPV, human papillomavirus, Ullrich said.

    Any review of priorities is sure to be contentious, though.

    The cancer society’s report is the first major effort to look at the economic cost in terms of global productivity. It was done with Livestrong, cancer survivor and cyclist Lance Armstrong’s foundation. Authors plan to publish it in a scientific journal and to present it Thursday at a meeting of the World Cancer Congress in Shenzen, China.

    Researchers used the World Health Organization’s death and disability reports, and economic data from the World Bank. They calculated disability-adjusted life years, which reflect the impact a disease has on how long and how productively people live.

    “That has become a more and more common way of looking at the global burden of disease,” said Wendy Max, a health economist at the University of California, San Francisco, who is familiar with the work and the methods the researchers used.

    Lung and related cancers account for $180 billion of the $895 billion total. Smokers die an average of 15 years earlier than nonsmokers, the report says. Heart disease follows cancer, with an economic impact of $753 billion.

    “Heart conditions usually hit people towards the end of their life. The cancers struck people much earlier in their life cycle,” said the lead author, cancer society health economist Hana Ross.

    In a separate article published online Monday by the British medical journal Lancet, cancer scientists and advocates urged more money to fight cancer in poor countries.

    Only 5 percent of cancer treatment and prevention money goes to the countries that bear 80 percent of the burden of the disease, said one of the authors, Dr. Julio Frenk, dean of Harvard’s School of Public Health.

    “We are literally being victims of our own success” – more people are surviving infectious diseases and living long enough to develop cancer, but treatment gaps remain, he said.

    Dr. Lawrence Shulman, chief medical officer of the Dana-Farber Cancer Institute in Boston, said cure rates for breast cancer are 80 percent or more in the U.S. and half that in many other countries.

    Many treatments are quite affordable “and could be successfully delivered in even the poorest settings,” he said.

    See full article here

      ...Read On

    A research position is available for a highly motivated post-doctoral fellow to join the research team of Dr. Brenda Gerull at the Libin Cardiovascular Institute (http://www.libin.ucalgary.ca) at the University of Calgary, Canada. Calgary is well-known as a destination for winter sports with a number of major mountain resorts near the city. Our laboratory is interested in molecular and genetic mechanisms of ‘Familial forms of heart failure’ in particular in the pathogenesis of Arrhythmogen…
    www.nature.com Full Story  ...Read On

    The reason why allergies are caused by nickel has been finally discovered by researchers. Researchers at University of Giessen, Germany found that the metal directly activates a member of the family of receptors that act as gatekeepers of innate immunity. According to Nature, activating this receptor, called Toll-like receptor 4 (TLR4), generates a 'danger signal' that promotes inflammation - causing itching, tenderness, swelling and rashes on the skin
    feedproxy.google.com Full Story  ...Read On

    Human red blood cells have been developed for the first time from embryonic stem cells by Brtish scientists working on a project to manufacture synthetic blood on an industrial scale. The aim of the 3million project is to develop an alternative source of O-negative blood, the universal donor group that can be transfused into the vast majority of the population without fear of rejection. The project, funded by the Wellcome Trust, has used more than
    feedproxy.google.com Full Story  ...Read On


    		   
    You can link to this article on your web site using following code:

    Website Code:

    Forum Code:  




     
    		 
    Comments

    We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.


    blog comments powered by Disqus
    Tags For This Article
    ,